SciBase Holding AB (publ) (SCIB.ST)
SEK 0.39
(2.36%)
SEK 0.39
(2.36%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 6.79 Million SEK | -16.31% |
| 2022 | 8.12 Million SEK | 183.89% |
| 2021 | 2.86 Million SEK | 49.09% |
| 2020 | 1.91 Million SEK | -65.55% |
| 2019 | 5.57 Million SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | -100.0% |
| 2013 | 258 Thousand SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.84 Million SEK | -19.12% |
| 2024 Q1 | 3.51 Million SEK | -48.3% |
| 2023 Q4 | 6.79 Million SEK | 46.8% |
| 2023 Q1 | 4.56 Million SEK | -43.75% |
| 2023 Q3 | 4.63 Million SEK | 18.08% |
| 2023 FY | 6.79 Million SEK | -16.31% |
| 2023 Q2 | 3.92 Million SEK | -14.18% |
| 2022 Q1 | 1.88 Million SEK | -34.18% |
| 2022 Q3 | 650 Thousand SEK | -48.78% |
| 2022 FY | 8.12 Million SEK | 183.89% |
| 2022 Q4 | 8.12 Million SEK | 1149.54% |
| 2022 Q2 | 1.26 Million SEK | -32.61% |
| 2021 Q2 | 1.52 Million SEK | 0.0% |
| 2021 Q4 | 2.86 Million SEK | 202.43% |
| 2021 Q3 | 946 Thousand SEK | -38.09% |
| 2021 Q1 | - SEK | -100.0% |
| 2021 FY | 2.86 Million SEK | 49.09% |
| 2020 Q3 | 2.15 Million SEK | -16.65% |
| 2020 Q4 | 1.91 Million SEK | -11.08% |
| 2020 Q1 | 3.01 Million SEK | -45.85% |
| 2020 FY | 1.91 Million SEK | -65.55% |
| 2020 Q2 | 2.58 Million SEK | -14.16% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 FY | 5.57 Million SEK | 0.0% |
| 2019 Q4 | 5.57 Million SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2014 FY | - SEK | -100.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2013 FY | 258 Thousand SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 99.579% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 99.579% |
| Arcoma AB | 3.87 Million SEK | -75.497% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | 97.084% |
| BICO Group AB (publ) | 1.85 Billion SEK | 99.633% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | 95.908% |
| CellaVision AB (publ) | 64.7 Million SEK | 89.495% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -1397.137% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -277.611% |
| Duearity AB (publ) | 10.58 Million SEK | 35.768% |
| Dignitana AB (publ) | 19.1 Million SEK | 64.421% |
| Episurf Medical AB (publ) | 5.2 Million SEK | -30.712% |
| Getinge AB (publ) | 8.07 Billion SEK | 99.916% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | 17.608% |
| Iconovo AB (publ) | 7.72 Million SEK | 12.012% |
| Integrum AB (publ) | 6.42 Million SEK | -5.803% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -3199.13% |
| Mentice AB (publ) | 9.55 Million SEK | 28.879% |
| OssDsign AB (publ) | 3.15 Million SEK | -115.778% |
| Paxman AB (publ) | 13.57 Million SEK | 49.912% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | 67.213% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | 78.618% |
| Sedana Medical AB (publ) | 4.3 Million SEK | -57.85% |
| Senzime AB (publ) | 11.46 Million SEK | 40.731% |
| SpectraCure AB (publ) | 6.71 Million SEK | -1.191% |
| Stille AB | 62.94 Million SEK | 89.201% |
| Vitrolife AB (publ) | 2.08 Billion SEK | 99.675% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | 78.379% |